Last reviewed · How we verify
Gemigliptin tartrate sesquihydrate and metformin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Gemigliptin tartrate sesquihydrate and metformin (Gemigliptin tartrate sesquihydrate and metformin) — LG Chem.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gemigliptin tartrate sesquihydrate and metformin TARGET | Gemigliptin tartrate sesquihydrate and metformin | LG Chem | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gemigliptin tartrate sesquihydrate and metformin CI watch — RSS
- Gemigliptin tartrate sesquihydrate and metformin CI watch — Atom
- Gemigliptin tartrate sesquihydrate and metformin CI watch — JSON
- Gemigliptin tartrate sesquihydrate and metformin alone — RSS
Cite this brief
Drug Landscape (2026). Gemigliptin tartrate sesquihydrate and metformin — Competitive Intelligence Brief. https://druglandscape.com/ci/gemigliptin-tartrate-sesquihydrate-and-metformin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab